Stefano Benvenuti | Head of Public Affairs and Market Access
Fondazione Telethon
Appearances:
Day 2 @ 11:15
Fondazione Telethon not-for-profit model: from research to distribution of ATMPs for ultra-rare conditions
Day 2 @ 11:45
Panel: Expanding patient access to multi-indication medicines in Europe through innovative agreements
Case study example of multi-year, multi-indication (MYMI) agreements in Belgium, Italy, Netherlands and UK
Day 2 @ 11:45
Eyes on the Future: RDH12 Gene Therapy for Inherited Childhood Blindness
last published: 14/Jul/26 09:15 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events